BAY 2413555

Last updated

BAY 2413555
BAY2413555.svg
Identifiers
  • 7-[(3R,4R)-3,4-dihydroxypyrrolidin-1-yl]-6-fluoro-4-oxo-N-[(2S)-3,3,4,4,4-pentafluorobutan-2-yl]-1-(2,4,6-trifluorophenyl)-1,8-naphthyridine-3-carboxamide
CAS Number
PubChem CID
Chemical and physical data
Formula C23H17F9N4O4
Molar mass 584.399 g·mol−1
3D model (JSmol)
  • C[C@@H](C(C(F)(F)F)(F)F)NC(=O)C1=CN(C2=NC(=C(C=C2C1=O)F)N3C[C@H]([C@@H](C3)O)O)C4=C(C=C(C=C4F)F)F
  • InChI=1S/C23H17F9N4O4/c1-8(22(28,29)23(30,31)32)33-21(40)11-5-36(17-12(25)2-9(24)3-13(17)26)19-10(18(11)39)4-14(27)20(34-19)35-6-15(37)16(38)7-35/h2-5,8,15-16,37-38H,6-7H2,1H3,(H,33,40)/t8-,15+,16+/m0/s1
  • Key:VTFWALACVWFKNO-OCJYXSBASA-N

BAY 2413555 is an experimental drug that acts as a potent and selective positive allosteric modulator of the Muscarinic acetylcholine receptor M2. It has been investigated as an agent to stabilise heart rhythm. [1]

References

  1. Vakalopoulos A, Basting D, Brechmann M, Teller H, Boultadakis Arapinis M, Straub A, et al. (November 2024). "Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance". Journal of Medicinal Chemistry. 67 (21): 19165–19187. doi:10.1021/acs.jmedchem.4c01590. PMID   39463278.